Literature DB >> 2983630

Increased anxiogenic effects of caffeine in panic disorders.

D S Charney, G R Heninger, P I Jatlow.   

Abstract

The effects of oral administration of caffeine (10 mg/kg) on behavioral ratings, somatic symptoms, blood pressure and plasma levels of 3-methoxy-4-hydroxyphenethyleneglycol (MHPG) and cortisol were determined in 17 healthy subjects and 21 patients meeting DSM-III criteria for agoraphobia with panic attacks or panic disorder. Caffeine produced significantly greater increases in subject-rated anxiety, nervousness, fear, nausea, palpitations, restlessness, and tremors in the patients compared with healthy subjects. In the patients, but not the healthy subjects, these symptoms were significantly correlated with plasma caffeine levels. Seventy-one percent of the patients reported that the behavioral effects of caffeine were similar to those experienced during panic attacks. Caffeine did not alter plasma MHPG levels in either the healthy subjects or patients. Caffeine increased plasma cortisol levels equally in the patient and healthy groups. Because caffeine is an adenosine receptor antagonist, these results suggest that some panic disorder patients may have abnormalities in neuronal systems involving adenosine. Patients with anxiety disorders may benefit by avoiding caffeine-containing foods and beverages.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2983630     DOI: 10.1001/archpsyc.1985.01790260027003

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  45 in total

Review 1.  Genetics of caffeine consumption and responses to caffeine.

Authors:  Amy Yang; Abraham A Palmer; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2010-06-09       Impact factor: 4.530

2.  Comparison of the behavioural effects of an adenosine A1/A2-receptor antagonist, CGS 15943A, and an A1-selective antagonist, DPCPX.

Authors:  G Griebel; M Saffroy-Spittler; R Misslin; D Remmy; E Vogel; J J Bourguignon
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Caffeine consumption among eating disorder patients: epidemiology, motivations, and potential of abuse.

Authors:  A Burgalassi; C E Ramacciotti; M Bianchi; E Coli; L Polese; E Bondi; G Massimetti; L Dell'osso
Journal:  Eat Weight Disord       Date:  2009-12       Impact factor: 4.652

Review 4.  An Active Inference Approach to Interoceptive Psychopathology.

Authors:  Martin P Paulus; Justin S Feinstein; Sahib S Khalsa
Journal:  Annu Rev Clin Psychol       Date:  2019-05-07       Impact factor: 18.561

5.  Interaction of carbamazepine and other drugs with adenosine (A1 and A2) receptors.

Authors:  Y Fujiwara; M Sato; S Otsuki
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

6.  ADORA2A Gene variation, caffeine, and emotional processing: a multi-level interaction on startle reflex.

Authors:  Katharina Domschke; Agnieszka Gajewska; Bernward Winter; Martin J Herrmann; Bodo Warrings; Andreas Mühlberger; Katherina Wosnitza; Evelyn Glotzbach; Annette Conzelmann; Andrea Dlugos; Manfred Fobker; Christian Jacob; Volker Arolt; Andreas Reif; Paul Pauli; Peter Zwanzger; Jürgen Deckert
Journal:  Neuropsychopharmacology       Date:  2011-10-19       Impact factor: 7.853

7.  Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder.

Authors:  R S Kahn; G M Asnis; S Wetzler; H M van Praag
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 8.  Pharmacological rationale for the clinical use of caffeine.

Authors:  J Sawynok
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

9.  Anxiolytic activity of adenosine receptor activation in mice.

Authors:  N Jain; N Kemp; O Adeyemo; P Buchanan; T W Stone
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

10.  Cerebral blood flow and metabolism in anxiety and anxiety disorders.

Authors:  R J Mathew
Journal:  Indian J Psychiatry       Date:  1994-07       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.